Summary
The global Oral Vaccines market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Live Attenuated Vaccines
Killed/Inactivated Vaccines
Recombinant Vaccines
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
GlaxoSmithKline Plc.
PaxVax Corporation
Pfizer Inc
Merial, Inc.
Merck Sharp & Dohme Corp
VALNEVA Canada Inc.
QU?MICA SUIZA S.A
Immunitor, Inc
Aventis (Sanofi S.A.)
Serum Institute of India Pvt. Ltd
Swiss Serum and Vaccine Institute Berne
Bull Bio - NCIPD Ltd.
Vaxart, Inc.
Shantha Biotechnics
Crucell (Janssen Global Services, LLC)
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Polio
Rabies
Rotavirus
Cholera
HIV
Respiratory Infections
Influenza
Tuberculosis
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Oral Vaccines Picture
1.1.2 Specifications
Table Product Specifications of Oral Vaccines
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Oral Vaccines
Table Global Oral Vaccines Market by Type, 2016-2026 (USD Million)
1.2.1.1 Live Attenuated Vaccines
Table Live Attenuated Vaccines Overview
1.2.1.2 Killed/Inactivated Vaccines
Table Killed/Inactivated Vaccines Overview
1.2.1.3 Recombinant Vaccines
Table Recombinant Vaccines Overview
1.2.1.4 Others
Table Others Overview
1.2.2 by Application
Table Application Segment of Oral Vaccines
Table Global Oral Vaccines Market by Application, 2016-2026 (USD Million)
1.2.2.1 Polio
Table Polio Overview
1.2.2.2 Rabies
Table Rabies Overview
1.2.2.3 Rotavirus
Table Rotavirus Overview
1.2.2.4 Cholera
Table Cholera Overview
1.2.2.5 HIV
Table HIV Overview
1.2.2.6 Respiratory Infections
Table Respiratory Infections Overview
1.2.2.7 Influenza
Table Influenza Overview
1.2.2.8 Tuberculosis
Table Tuberculosis Overview
1.2.2.9 Others
Table Others Overview
1.2.3 by Regions
Table Global Oral Vaccines Market by Region, 2016-2026 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Oral Vaccines
2.2 Upstream
Table Cost of Oral Vaccines
Figure Manufacturing Process of Oral Vaccines
2.3 Market
2.3.1 SWOT
Figure SWOT of Oral Vaccines
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Oral Vaccines
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Oral Vaccines
3.4 Market Entry
Table Market Entry of Oral Vaccines
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Live Attenuated Vaccines Market, 2016-2020
Figure Live Attenuated Vaccines Market Size and Growth, 2016-2020 (USD Million)
Figure Live Attenuated Vaccines Market Size and Growth, 2016-2020 (in Volume)
Table Live Attenuated Vaccines CAGR by Revenue and Volume, 2016-2020
4.1.2 Killed/Inactivated Vaccines Market, 2016-2020
Figure Killed/Inactivated Vaccines Market Size and Growth, 2016-2020 (USD Million)
Figure Killed/Inactivated Vaccines Market Size and Growth, 2016-2020 (in Volume)
Table Killed/Inactivated Vaccines CAGR by Revenue and Volume, 2016-2020
4.1.3 Recombinant Vaccines Market, 2016-2020
Figure Recombinant Vaccines Market Size and Growth, 2016-2020 (USD Million)
Figure Recombinant Vaccines Market Size and Growth, 2016-2020 (in Volume)
Table Recombinant Vaccines CAGR by Revenue and Volume, 2016-2020
4.1.4 Others Market, 2016-2020
Figure Others Market Size and Growth, 2016-2020 (USD Million)
Figure Others Market Size and Growth, 2016-2020 (in Volume)
Table Others CAGR by Revenue and Volume, 2016-2020
4.2 Market Forecast
4.2.1 Live Attenuated Vaccines Market Forecast, 2021-2026
Figure Live Attenuated Vaccines Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Live Attenuated Vaccines Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Live Attenuated Vaccines CAGR by Revenue and Volume, 2016-2026
4.2.2 Killed/Inactivated Vaccines Market Forecast, 2021-2026
Figure Killed/Inactivated Vaccines Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Killed/Inactivated Vaccines Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Killed/Inactivated Vaccines CAGR by Revenue and Volume, 2016-2026
4.2.3 Recombinant Vaccines Market Forecast, 2021-2026
Figure Recombinant Vaccines Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Recombinant Vaccines Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Recombinant Vaccines CAGR by Revenue and Volume, 2016-2026
4.2.4 Others Market Forecast, 2021-2026
Figure Others Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Others Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Others CAGR by Revenue and Volume, 2016-2026
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Polio Market, 2016-2020
Figure Polio Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Polio CAGR by Revenue and Volume, 2016-2020
5.1.2 Rabies Market, 2016-2020
Figure Rabies Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Rabies CAGR by Revenue and Volume, 2016-2020
5.1.3 Rotavirus Market, 2016-2020
Figure Rotavirus Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Rotavirus CAGR by Revenue and Volume, 2016-2020
5.1.4 Cholera Market, 2016-2020
Figure Cholera Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Cholera CAGR by Revenue and Volume, 2016-2020
5.1.5 HIV Market, 2016-2020
Figure HIV Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table HIV CAGR by Revenue and Volume, 2016-2020
5.1.6 Respiratory Infections Market, 2016-2020
Figure Respiratory Infections Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Respiratory Infections CAGR by Revenue and Volume, 2016-2020
5.1.7 Influenza Market, 2016-2020
Figure Influenza Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Influenza CAGR by Revenue and Volume, 2016-2020
5.1.8 Tuberculosis Market, 2016-2020
Figure Tuberculosis Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Tuberculosis CAGR by Revenue and Volume, 2016-2020
5.1.9 Others Market, 2016-2020
Figure Others Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Others CAGR by Revenue and Volume, 2016-2020
5.2 Market Forecast
5.2.1 Polio Market Forecast, 2021-2026
Figure Polio Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Polio Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Polio CAGR by Revenue and Volume, 2021-2026
5.2.2 Rabies Market Forecast, 2021-2026
Figure Rabies Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Rabies Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Rabies CAGR by Revenue and Volume, 2021-2026
5.2.3 Rotavirus Market Forecast, 2021-2026
Figure Rotavirus Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Rotavirus Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Rotavirus CAGR by Revenue and Volume, 2021-2026
5.2.4 Cholera Market Forecast, 2021-2026
Figure Cholera Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Cholera Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Cholera CAGR by Revenue and Volume, 2021-2026
5.2.5 HIV Market Forecast, 2021-2026
Figure HIV Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure HIV Market Estimates and Forecasts, 2021-2026 (in Volume)
Table HIV CAGR by Revenue and Volume, 2021-2026
5.2.6 Respiratory Infections Market Forecast, 2021-2026
Figure Respiratory Infections Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Respiratory Infections Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Respiratory Infections CAGR by Revenue and Volume, 2021-2026
5.2.7 Influenza Market Forecast, 2021-2026
Figure Influenza Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Influenza Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Influenza CAGR by Revenue and Volume, 2021-2026
5.2.8 Tuberculosis Market Forecast, 2021-2026
Figure Tuberculosis Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Tuberculosis Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Tuberculosis CAGR by Revenue and Volume, 2021-2026
5.2.9 Others Market Forecast, 2021-2026
Figure Others Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Others Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Others CAGR by Revenue and Volume, 2021-2026
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2016-2020
Figure Asia-Pacific Market Size and Growth, 2016-2020 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2016-2020 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2016-2020
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2016-2020
Figure North America Market Size and Growth, 2016-2020 (USD Million)
Figure North America Market Size and Growth, 2016-2020 (in Volume)
Table North America CAGR by Revenue and Volume, 2016-2020
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2016-2020
Figure Europe Market Size and Growth, 2016-2020 (USD Million)
Figure Europe Market Size and Growth, 2016-2020 (in Volume)
Table Europe CAGR by Revenue and Volume, 2016-2020
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2016-2020
Figure South America Market Size and Growth, 2016-2020 (USD Million)
Figure South America Market Size and Growth, 2016-2020 (in Volume)
Table South America CAGR by Revenue and Volume, 2016-2020
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2016-2020
Figure Middle East & Africa Market Size and Growth, 2016-2020 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2016-2020 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2016-2020
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2021-2026
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2021-2026
6.2.2 North America Market Forecast, 2021-2026
Figure North America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure North America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table North America CAGR by Revenue and Volume, 2021-2026
6.2.3 Europe Market Forecast, 2021-2026
Figure Europe Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Europe Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Europe CAGR by Revenue and Volume, 2021-2026
6.2.4 South America Market Forecast, 2021-2026
Figure South America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure South America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table South America CAGR by Revenue and Volume, 2021-2026
6.2.5 Middle East & Africa Market Forecast, 2021-2026
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2021-2026
7 Market Competitive
7.1 Global Market by Vendors
Table Global Oral Vaccines Market by Vendors, 2016-2020 (in Volume)
Table Global Oral Vaccines Market Share by Vendors, 2016-2020 (USD Million)
Table Global Oral Vaccines Market Share by Vendors, 2016-2020 (in Volume)
7.2 Market Concentration
Figure Oral Vaccines Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 GlaxoSmithKline Plc.
Table GlaxoSmithKline Plc. Profile List
Table Microecological Modulator Operating Data of GlaxoSmithKline Plc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 PaxVax Corporation
Table PaxVax Corporation Profile List
Table Microecological Modulator Operating Data of PaxVax Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Pfizer Inc
Table Pfizer Inc Profile List
Table Microecological Modulator Operating Data of Pfizer Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Merial, Inc.
Table Merial, Inc. Profile List
Table Microecological Modulator Operating Data of Merial, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Merck Sharp & Dohme Corp
Table Merck Sharp & Dohme Corp Profile List
Table Microecological Modulator Operating Data of Merck Sharp & Dohme Corp (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 VALNEVA Canada Inc.
Table VALNEVA Canada Inc. Profile List
Table Microecological Modulator Operating Data of VALNEVA Canada Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 QU